Du Xiao Fei, Jiang Cheng Zhe, Wu Chun Fu, Won Eun Kyung, Choung Se Young
Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang, China.
Pharmazie. 2008 Dec;63(12):904-8.
We investigated the synergistic effect of pidotimod and red ginseng acidic polysaccharide (RGAP) from Panax ginseng C.A. Meyer on humoral immune response challenged by lipopolysaccharide (LPS) and sheep red blood cells (SRBC) in immunosuppressed mice. Combined treatment with pidotimod and RGAP significantly increased the number of plaque-forming cells in the spleen in response to both LPS and SRBC, while treatment with either pidotimod or RGAP individually had no such effect. IgG levels in serum were augmented for secondary responses to SRBC in co-treated mice, but not in mice treated with either drug alone. Microscopic studies revealed that architecture of the spleen, thymus, and lymph nodes was conserved. GPT and creatinine in serum as indicators of hepatic and renal functions showed no difference compared to the control group. These results indicate that combined treatment with pidotimod and RGAP has an immunostimulatory effect in a synergistic manner on antibody response to challenge with LPS and SRBC without toxic changes.
我们研究了匹多莫德与人参(Panax ginseng C.A. Meyer)红参酸性多糖(RGAP)对免疫抑制小鼠体内脂多糖(LPS)和绵羊红细胞(SRBC)激发的体液免疫反应的协同作用。匹多莫德与RGAP联合治疗显著增加了脾脏中针对LPS和SRBC的噬斑形成细胞数量,而单独使用匹多莫德或RGAP治疗则没有这种效果。联合治疗的小鼠对SRBC二次反应的血清IgG水平升高,但单独使用任何一种药物治疗的小鼠则没有。显微镜研究显示脾脏、胸腺和淋巴结的结构保持完整。作为肝肾功能指标的血清谷丙转氨酶(GPT)和肌酐与对照组相比无差异。这些结果表明,匹多莫德与RGAP联合治疗对LPS和SRBC激发的抗体反应具有协同免疫刺激作用,且无毒性变化。